Eveliqure Biotechnologies GmbH today announces the award of a US government contract from the National Institute of Allergy and Infectious Diseases (NIAID), contract #75N93020C00048 with the intent to fund the development of its vaccine candidate, ShigETEC, through Phase 2 clinical testing.
Award of the National Institute of Allergy and Infectious Diseases (NIAID)
